Kinross Gold Class Action | KGC

On November 6, 2026, a securities class action complaint was filed against Kinross Gold Corporation (“Kinross” or the “Company”) (NYSE: KGC) on behalf of all investors who purchased or otherwise acquired Kinross common stock between February 18, 2026 and September 23, 2026, inclusive (the “Class Period”).

The action, Lin v. Kinross Gold Corporation, et al., was filed in United States District Court for the District of Colorado and asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

Kinross Gold Securities Class Action Allegations

According to the complaint, defendants made materially false and/or misleading statements and concealed material adverse facts concerning Kinross’ production guidance. The complaint alleges that defendants repeatedly expressed confidence in production of approximately 2 million gold equivalent ounces annually for 2026 through 2028, while Kinross lacked the necessary resources and/or was otherwise ill-equipped to achieve those projections. The complaint further alleges that defendants minimized risks associated with continued production declines at Round Mountain Phase S and failed to adequately disclose risks associated with the mining equipment used at that operation.

Kinross Cuts Production Guidance; Shares Decline

On September 23, 2026, Kinross announced that it expected attributable production of approximately 1.84 million to 1.86 million gold equivalent ounces annually in 2026 and 2027, below its previously disclosed guidance. The Company attributed the reduction to extreme weather and operational challenges at La Coipa and Round Mountain, including lower mining rates, grades, and recoveries at Round Mountain Phase S. According to the complaint, Kinross subsequently discussed potential ore dilution associated with the use of larger mining equipment at Round Mountain.

Following the announcement, Kinross common stock declined $3.20 per share, or approximately 11.5%, from a closing price of $27.62 on September 23, 2026 to $24.42 on September 24, 2026.

January 5, 2027 Lead Plaintiff Deadline

Kinross Gold investors have until January 5, 2027 to move the Court for appointment as lead plaintiff. Investors do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

Kinross Gold (KGC) Investors: Contact Kehoe Law Firm

If you purchased Kinross common stock during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the class action and your legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

 

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Ionis Pharmaceuticals Securities Investigation | IONS

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS) following the Company’s November 9, 2026 announcement substantially reducing its full-year 2026 sales forecast for TRYNGOLZA (olezarsen).

On November 9, 2026, Ionis announced that it was lowering its 2026 TRYNGOLZA sales guidance from $100 million–$110 million to approximately $50 million, citing a slower-than-anticipated commercial launch.

Previously, Ionis had expressed confidence in TRYNGOLZA’s commercial launch and its ability to achieve the Company’s sales guidance. The November 9, 2026, disclosures raise questions concerning whether Ionis adequately disclosed adverse sales trends and commercialization challenges known to management during the third quarter.

Following the announcement, Ionis shares declined approximately 20% in premarket trading on November 9, 2026.

Ionis (IONS) Investors:

If you purchased or otherwise acquired Ionis securities and suffered financial losses, you are encouraged to contact Kehoe Law Firm or Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

MNTN Securities Investigation | MNTN

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of MNTN, Inc. (“MNTN” or the “Company”) (MNTN: NYSE) following the Company’s November 4, 2026 disclosures concerning sales force attrition, disappointing third-quarter results, and reduced financial guidance.

On August 4, 2026, MNTN announced its second-quarter financial results and provided third-quarter revenue guidance of $86 million to $89 million and adjusted EBITDA guidance of $22 million to $25 million. The Company also projected full-year 2026 revenue of $347 million to $357 million and adjusted EBITDA of $96 million to $101 million.

During the Company’s August 4 earnings conference call, then-CEO Mark Douglas discussed MNTN’s investments in its sales organization and described its products and go-to-market structure as: “ready to execute at greater scale.” Douglas also discussed the Company’s development of specialized, industry-focused sales teams, stating: “That knowledge makes our sales process and the customer experience more effective.”

On November 4, 2026, MNTN reported third-quarter revenue of approximately $80.3 million and adjusted EBITDA of approximately $19.9 million, both below the Company’s August guidance. MNTN also substantially lowered its full-year financial outlook, projecting revenue of approximately $311 million to $314 million and adjusted EBITDA of approximately $66 million to $68 million.

During the November 4 earnings conference call, newly appointed CEO Tony Weisman attributed the disappointing results to significant disruptions involving the Company’s sales organization. Weisman disclosed: “We lost about 40% of our experienced quota-carrying sellers”

Weisman further explained that changes to the Company’s sales structure and employee compensation arrangements contributed to the departures and adversely affected its ability to acquire new customers. Significantly, when discussing the timing of these changes, Weisman stated: “These were told to the team in late Q2”

On this news, MNTN’s stock proce closed down more than 54% on November 5, 2026.

MNTN (NYSE: MNTN) Investors:

If you purchased or otherwise acquired MNTN securities and suffered financial losses, you are encouraged to contact Kehoe Law Firm or Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Amdocs Securities Investigation | DOX

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Amdocs Limited (“Amdocs” or the “Company”) (NASDAQ: DOX) following the Company’s November 3, 2026 disclosures concerning a contractual dispute with T-Mobile and its fiscal 2027 financial outlook.

On November 3, 2026, Amdocs announced its fourth-quarter and full-year fiscal 2026 results and disclosed that it and T-Mobile had exchanged notices alleging material breaches of their software and services agreements. Both parties threatened termination and/or monetary or other relief, including arbitration.

Amdocs also projected that fiscal 2027 reported revenue would decline 14.3% to 17.9% year over year and non-GAAP diluted earnings per share would decline 26% to 30%. The Company stated that its outlook reflected the T-Mobile dispute, reduced discretionary spending by T-Mobile, and completion of the USCellular customer integration project.

Following the November 3 disclosures, Amdocs shares traded down at least 29% during intraday trading on November 4, 2026.

Amdocs (DOX) Investors: 

If you purchased or otherwise acquired Amdocs securities and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the investigation and your legal rights.

For a free, no-obligation legal evaluation, contact:

John Kehoe, Esq.
(215) 792-6676, Ext. 801
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Stevanato Group Securities Investigation | STVN

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Stevanato Group S.p.A. (“Stevanato” or the “Company”) (NYSE: STVN) following the Company’s November 3, 2026 disclosures and the resulting decline in its stock price.

On November 3, 2026, Stevanato announced its third-quarter financial results and disclosed that it anticipated lower GLP-1-related volumes and revenue in 2027 than previously expected.  GLP-1 therapies accounted for approximately 17% to 18% of the Company’s third-quarter revenue. Management indicated that the anticipated shortfall would temporarily moderate the Company’s growth in 2027, with revenue growth expected to be in the low single digits.

Stevanato had previously characterized the GLP-1 market as an important, durable source of growth.  The November 3 disclosures raise questions regarding the Company’s prior statements concerning GLP-1-related demand, customer-volume expectations, the visibility of future revenue, and whether investors were adequately informed of risks to the Company’s growth outlook.

Following the November 3, 2026 announcement, Stevanato shares declined $5.64 per share, or 28.57%, closing at $14.10 per share.

Stevanato Group (STVN) Investors: 

If you purchased or otherwise acquired Stevanato securities and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the investigation and your legal rights.

For a free, no-obligation legal evaluation, contact:

John Kehoe, Esq.
(215) 792-6676, Ext. 801
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]